6,000,000 Shares Fate Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENT May 20, 2015Underwriting Agreement • May 21st, 2015 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledMay 21st, 2015 Company Industry Jurisdiction